Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
To achieve maximum effect with safety, maintain regular checkups and follow the doctors advice
Verdict at a Glance CagriSema and tirzepatide achieve remarkably similar weight loss (20.4% vs 20.9%) through fundamentally different dual mechanisms -- amylin/GLP-1 versus GIP/GLP-1
For the BMI cohort, exploratory BMI outcomes were measured using ICD-10-CM codes and included change in BMI from baseline to follow-up and proportion of individuals with decreasing BMI category from baseline to follow-up
Signs of elevated blood sugar may include: Persistent thirst A dry mouth Nausea Feeling unusually fatigued (especially after eating) Some individuals may also notice their breath smells slightly sweet or fruity, or they feel short of breath during normal activities
It stated that overall clinical benefit was found in 89% of patients
In the SURMOUNT-1 trial, which evaluated tirzepatide for chronic weight management in adults without diabetes, approximately 67% of participants were women
